MiNK Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
MiNK Therapeutics, Inc. (INKT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 77.14 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 77.14K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 70.83K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 77.87K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 75.31K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2026-06-30 | 77.14K shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 70.83K shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 77.87K shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 75.31K shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 80.65K shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 89.68K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 80.65K shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 784.58K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 770.42K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 781.89K shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 78.95K shares 10-K · filed 2025-03-18 | 789.50K shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 766.79K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 756.52K shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 885.76K shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 726.16K shares 10-K · filed 2024-03-21 | |
| 2022-09-30 | 756.35K shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 695.75K shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 848.78K shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 723.58K shares 10-K · filed 2023-03-24 | |
| 2021-09-30 | 751.41K shares 10-Q · filed 2021-11-29 | |
| 2020-12-31 | 55.66K shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |